New drug aims to cut blood removal in rare cancer

NCT ID NCT07648030

Recruiting now Disease control Sponsor: Takeda Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 4 times

Summary

This trial tests rusfertide, an injected drug, in Japanese adults with polycythemia vera, a rare blood cancer that causes too many red blood cells. The goal is to see if rusfertide can keep red blood cell levels under control and reduce the need for phlebotomy (blood removal). All participants receive rusfertide, and the study tracks their response over about 52 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: rusfertide
What this could lead to: If successful, rusfertide could offer a way to manage polycythemia vera with fewer blood removal procedures.
What could go wrong: This is a small, early-phase study with only 9 participants, so results may not apply broadly. The drug may not work as hoped or could cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLYCYTHEMIA VERA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired polycythemia vera

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POLYCYTHEMIA VERA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Gunma University Hospital
NOT_YET_RECRUITING

Maebashi, Gunma, Japan
Juntendo University Hospital
RECRUITING

Bunkyo-ku, Tokyo, Japan
Mie University Hospital
RECRUITING

Tsu, Mie-ken, Japan
Nagoya Medical Center
NOT_YET_RECRUITING

Nagoya, Aichi-ken, Japan
Tokyo Medical University Hospital
NOT_YET_RECRUITING

Shinjuku-ku, Tokyo, Japan
Tokyo Metropilitan Bokutoh Hospital
NOT_YET_RECRUITING

Sumida-ku, Tokyo, Japan
University of Miyazaki Hospital
NOT_YET_RECRUITING

Miyazaki, Japan
University of Osaka Hospital
RECRUITING

Suita, Osaka, Japan
University of Yamanashi Hospital
RECRUITING

Chūō, Yamanashi, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.